Barry Fishman's most recent trade in Medicus Pharma Ltd was a trade of 25,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on July 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Medicus Pharma Ltd | Barry Fishman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2025 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Akerna Corp | Barry Fishman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2022 | 3,486 | 10,458 | - | - | Restricted Stock Units | |
| Akerna Corp | Barry Fishman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2022 | 3,486 | 6,132 (0%) | 0% | - | Common Shares | |
| Akerna Corp | Barry Fishman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 13,944 | 13,944 | - | - | Restricted Stock Units |